(IQSU) IQ Candriam ESG US Equity - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US45409B4611 • Large Blend
IQSU: Stocks, US, Equities, ESG, Index, Fund
The IQ Candriam ESG US Equity ETF (NYSE ARCA: IQSU) is a passively managed exchange-traded fund designed to replicate the performance of an underlying index focused on US equities that meet specific environmental, social, and governance (ESG) criteria. The index is constructed using a market capitalization weighting methodology, ensuring that larger companies have a greater influence on its performance. This ETF is categorized as a Large Blend fund, indicating its exposure to both growth and value stocks within the US large-cap equity market.
Ticker Symbol: IQSU | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Large Blend
From a technical perspective, IQSU currently trades at $47.62, with a 20-day average volume of 9,247 shares. The ETFs short-term moving averages (SMA 20: $49.19, SMA 50: $49.16) are above its current price, suggesting potential near-term weakness. However, the 200-day moving average (SMA 200: $47.17) is below the current price, indicating that the ETF is in a longer-term uptrend. The Average True Range (ATR) of 0.53 reflects relatively low volatility.
Fundamentally, IQSU manages approximately $381.07 million in assets under management (AUM), making it a moderately sized ETF in its category. The funds ESG criteria, developed by Candriam, focus on companies demonstrating strong environmental stewardship, social responsibility, and sound corporate governance practices. The market capitalization weighting ensures that the ETFs returns are heavily influenced by the performance of its largest holdings.
3-Month Forecast: Based on the current technical and fundamental data, IQSU is expected to trade within a narrow range over the next three months. The ETFs short-term moving averages suggest potential downside risk, but the longer-term uptrend and low volatility (ATR: 0.53) indicate stability. If market conditions remain favorable for ESG-focused investments, IQSU could experience modest gains, supported by its exposure to large-cap US equities. However, any broader market downturn could lead to a slight correction in the ETFs price.
Additional Sources for IQSU ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IQSU ETF Overview
Market Cap in USD | 333m |
Category | Large Blend |
TER | 0.09% |
IPO / Inception | 2019-12-17 |
IQSU ETF Ratings
Growth Rating | 71.8 |
Fundamental | - |
Dividend Rating | 58.5 |
Rel. Strength | -5.13 |
Analysts | - |
Fair Price Momentum | 41.00 USD |
Fair Price DCF | - |
IQSU Dividends
Dividend Yield 12m | 1.20% |
Yield on Cost 5y | 2.46% |
Annual Growth 5y | 11.36% |
Payout Consistency | 85.7% |
IQSU Growth Ratios
Growth Correlation 3m | -88.2% |
Growth Correlation 12m | 57.6% |
Growth Correlation 5y | 84.2% |
CAGR 5y | 14.54% |
CAGR/Max DD 5y | 0.54 |
Sharpe Ratio 12m | 1.06 |
Alpha | -5.67 |
Beta | 1.030 |
Volatility | 50.08% |
Current Volume | 4.8k |
Average Volume 20d | 3.6k |
As of April 15, 2025, the stock is trading at USD 43.44 with a total of 4,823 shares traded.
Over the past week, the price has changed by +6.67%, over one month by -4.04%, over three months by -9.10% and over the past year by +2.68%.
Yes. Based on ValueRay Analyses, IQ Candriam ESG US Equity (NYSE ARCA:IQSU) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.83 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IQSU as of April 2025 is 41.00. This means that IQSU is currently overvalued and has a potential downside of -5.62%.
IQ Candriam ESG US Equity has no consensus analysts rating.
According to ValueRays Forecast Model, IQSU IQ Candriam ESG US Equity will be worth about 45.7 in April 2026. The stock is currently trading at 43.44. This means that the stock has a potential upside of +5.09%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.7 | 5.1% |